Faculty Information - Tsukigawa Kenji

Tsukigawa Kenji

Department / Course FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences

Job

Academic conference presentation
1.	2022/11	Lysophospholipase D activity of intact kidney-derived cell line, NKR52E: possibly due to glycerophosphodisetrease 7
2.	2022/05	Masking the foul taste of 4-phenylbutyrate to improve compliance: the case of cyclodextrin complexation (日本薬剤学会第37年会)
3.	2021/05	Investigation of the interaction between 4-phenylbutyric acid and cyclodextrins (日本薬剤学会第36年会)
4.	2016/10	Comparison of pegylated zinc protoporphyrin with different chemical bonds in stability during blood circulation, drug release by depegylation in tumor tissue, and antitumor effect (第31回年会日本薬物動態学会)
5.	2015/09	Influence of different chemical bonds in pegylation of zinc protoporphyrin on depegylation, cellular uptake, and antitumor activity (The Academy of Pharmaceutical Science and Technology, Japan, Global Education Seminar　2015-1st)
6.	2015/07	Styrene-maleic acid copolymer conjugated pirarubicin , an anticancer nanomedicine with good stability and tumor-targeting property (42th Annual Meeting and Exposition of the Controlled Release Society)
7.	2014/11	Pharmacokinetic properties and antitumor activity of styrene maleic acid copolymer conjugated pirarubicin (第8回次世代を担う若手医療薬科学シンポジウム)
8.	2013/10	Two step tumor-selective action of pirarubicin-conjugated N-(2-hydroxypropyl) methacrylamide copolymer (第72回日本癌学会学術総会)
9.	2013/10	Targeting of SMA-pirarubicine nanomedicine to the metastatic lung cancer: therapeutic effect and imaging (第72回日本癌学会学術総会)
10.	2013/07	EPR effect in metastatic and autochthonous tumor and antimetastatic effect of SMA-pirarubicin (THP) (40th Annual Meeting and Exposition of the Controlled Release Society)
11.	2013/07	Double selective antitumor action of pirarubicin-conjugated N-(2-hydroxypropyl) methacrylamide copolymer (40th Annual Meeting and Exposition of the Controlled Release Society)
12.	2013/03	The EPR effect and beyond for cancer selective drug delivery and imaging (2nd International Conference on Biomaterials Science)
13.	2013/03	Antitumor effect of styrene- maleic acid copolymer (SMA) derivative conjugated pirarubicin (THP) (2nd International Conference on Biomaterials Science)
14.	2012/08	Distinct tumor targeting and fluorescent imaging using nanoparticle based on EPR effect: Toward fluorescent endoscopy (第71回日本癌学会学術総会)
15.	2012/08	Antitumor activity of pirarubicin conjugated HPMA copolymer via acid labile linkage (第71回日本癌学会学術総会)
16.	2012/07	Tumor selective delivery of Zn-Protoporphyrin conjugated hydroxypropylmethacrylamide polymer (HPMA) micelle for imaging and light induced antitumor effect (39th Annual Meeting and Exposition of the Controlled Release Society)
17.	2012/05	The EPR effect as seen by tumor imaging of fluorescent proteins and synthetic nanoparticles (9th International Symposium on Polymer Therapeutics)
18.	2011/07	The importance of cleavage of PEG chains from pegylated zinc protoporphyrin (PEG-ZnPP) by tumor proteases on intracellular uptake (38th Annual Meeting and Exposition of the Controlled Release Society)
19.	2010/07	Intracellular uptake of water-soluble ZnPP micelles (SMA-ZnPP and PEG-ZnPP) and the unique release mechanism of the drug from their micelles (37th Annual Meeting and Exposition of the Controlled Release Society)
20.	2010/07	Effects of pegylation in intracellular uptake and depegylation for drug release in pegylated zinc protoporphyrin (PEG-ZnPP) micelle (37th Annual Meeting and Exposition of the Controlled Release Society)